Vanta Bioscience Ltd
BSE:540729
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vanta Bioscience Ltd
BSE:540729
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
VANTABIO
stock under the Base Case scenario is
12.08
INR.
Compared to the current market price of 15.2 INR,
Vanta Bioscience Ltd
is
Overvalued by 21%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
VANTABIO Competitors Multiples
Vanta Bioscience Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Vanta Bioscience Ltd
BSE:540729
|
108.1m INR | 8.8 | -2.4 | -7.9 | -4.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
956.9B USD | 335.1 | 3 967.4 | 1 136.9 | 2 189.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.2B USD | 4.3 | 28.3 | 19.6 | 26.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
135B USD | 5.6 | 38.4 | 19.5 | 28.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
302.3B CNY | 6.6 | 15.8 | 16.5 | 16.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.5B CHF | 5.4 | 37 | 27.5 | 27.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.2B USD | 4.7 | 25.6 | 18.8 | 22.2 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.2B USD | 9.9 | 48.8 | 31.5 | 39.6 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.9B USD | 1.8 | 21.6 | 12 | 18 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.9B USD | 6.7 | 31 | 23 | 25.5 |